In addition, pristane may induce ANAs, anti-dsDNA, and anti-SnRNP antibodies and show an overproduction of type I IFN, which makes it very suitable as a model for SLE since high amounts of type I IFN are observed in 50% of SLE patients [60]. The gene discussed is LSM2; the disease is systemic lupus erythematosus.